List of Tables
Table 1. Global Chronic Hepatitis B Oral Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Chronic Hepatitis B Oral Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Chronic Hepatitis B Oral Drugs Market Competitive Situation by Manufacturers in 2024
Table 4. Global Chronic Hepatitis B Oral Drugs Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Chronic Hepatitis B Oral Drugs Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Chronic Hepatitis B Oral Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Chronic Hepatitis B Oral Drugs Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Chronic Hepatitis B Oral Drugs Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Chronic Hepatitis B Oral Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Chronic Hepatitis B Oral Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Chronic Hepatitis B Oral Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Chronic Hepatitis B Oral Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Chronic Hepatitis B Oral Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Hepatitis B Oral Drugs as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Chronic Hepatitis B Oral Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Chronic Hepatitis B Oral Drugs Sales by Region (2020-2025) & (K Units)
Table 18. Global Chronic Hepatitis B Oral Drugs Sales Market Share by Region (2020-2025)
Table 19. Global Chronic Hepatitis B Oral Drugs Sales by Region (2026-2031) & (K Units)
Table 20. Global Chronic Hepatitis B Oral Drugs Sales Market Share by Region (2026-2031)
Table 21. Global Chronic Hepatitis B Oral Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Chronic Hepatitis B Oral Drugs Revenue Market Share by Region (2020-2025)
Table 23. Global Chronic Hepatitis B Oral Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Chronic Hepatitis B Oral Drugs Revenue Market Share by Region (2026-2031)
Table 25. North America Chronic Hepatitis B Oral Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Chronic Hepatitis B Oral Drugs Sales by Country (2020-2025) & (K Units)
Table 27. North America Chronic Hepatitis B Oral Drugs Sales by Country (2026-2031) & (K Units)
Table 28. North America Chronic Hepatitis B Oral Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Chronic Hepatitis B Oral Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Chronic Hepatitis B Oral Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Chronic Hepatitis B Oral Drugs Sales by Country (2020-2025) & (K Units)
Table 32. Europe Chronic Hepatitis B Oral Drugs Sales by Country (2026-2031) & (K Units)
Table 33. Europe Chronic Hepatitis B Oral Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Chronic Hepatitis B Oral Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Chronic Hepatitis B Oral Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Chronic Hepatitis B Oral Drugs Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Chronic Hepatitis B Oral Drugs Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Chronic Hepatitis B Oral Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Chronic Hepatitis B Oral Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Chronic Hepatitis B Oral Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Chronic Hepatitis B Oral Drugs Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Chronic Hepatitis B Oral Drugs Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Chronic Hepatitis B Oral Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Chronic Hepatitis B Oral Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Chronic Hepatitis B Oral Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Chronic Hepatitis B Oral Drugs Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Chronic Hepatitis B Oral Drugs Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Chronic Hepatitis B Oral Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Chronic Hepatitis B Oral Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Chronic Hepatitis B Oral Drugs Sales (K Units) by Type (2020-2025)
Table 51. Global Chronic Hepatitis B Oral Drugs Sales (K Units) by Type (2026-2031)
Table 52. Global Chronic Hepatitis B Oral Drugs Sales Market Share by Type (2020-2025)
Table 53. Global Chronic Hepatitis B Oral Drugs Sales Market Share by Type (2026-2031)
Table 54. Global Chronic Hepatitis B Oral Drugs Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Chronic Hepatitis B Oral Drugs Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Chronic Hepatitis B Oral Drugs Revenue Market Share by Type (2020-2025)
Table 57. Global Chronic Hepatitis B Oral Drugs Revenue Market Share by Type (2026-2031)
Table 58. Global Chronic Hepatitis B Oral Drugs Price (US$/Unit) by Type (2020-2025)
Table 59. Global Chronic Hepatitis B Oral Drugs Price (US$/Unit) by Type (2026-2031)
Table 60. Global Chronic Hepatitis B Oral Drugs Sales (K Units) by Application (2020-2025)
Table 61. Global Chronic Hepatitis B Oral Drugs Sales (K Units) by Application (2026-2031)
Table 62. Global Chronic Hepatitis B Oral Drugs Sales Market Share by Application (2020-2025)
Table 63. Global Chronic Hepatitis B Oral Drugs Sales Market Share by Application (2026-2031)
Table 64. Global Chronic Hepatitis B Oral Drugs Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Chronic Hepatitis B Oral Drugs Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Chronic Hepatitis B Oral Drugs Revenue Market Share by Application (2020-2025)
Table 67. Global Chronic Hepatitis B Oral Drugs Revenue Market Share by Application (2026-2031)
Table 68. Global Chronic Hepatitis B Oral Drugs Price (US$/Unit) by Application (2020-2025)
Table 69. Global Chronic Hepatitis B Oral Drugs Price (US$/Unit) by Application (2026-2031)
Table 70. GSK Company Information
Table 71. GSK Description and Business Overview
Table 72. GSK Chronic Hepatitis B Oral Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. GSK Chronic Hepatitis B Oral Drugs Product
Table 74. GSK Recent Developments/Updates
Table 75. Bristol Myers Squibb Company Information
Table 76. Bristol Myers Squibb Description and Business Overview
Table 77. Bristol Myers Squibb Chronic Hepatitis B Oral Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Bristol Myers Squibb Chronic Hepatitis B Oral Drugs Product
Table 79. Bristol Myers Squibb Recent Developments/Updates
Table 80. Gilead Sciences Company Information
Table 81. Gilead Sciences Description and Business Overview
Table 82. Gilead Sciences Chronic Hepatitis B Oral Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Gilead Sciences Chronic Hepatitis B Oral Drugs Product
Table 84. Gilead Sciences Recent Developments/Updates
Table 85. Novartis Company Information
Table 86. Novartis Description and Business Overview
Table 87. Novartis Chronic Hepatitis B Oral Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Novartis Chronic Hepatitis B Oral Drugs Product
Table 89. Novartis Recent Developments/Updates
Table 90. Roche Company Information
Table 91. Roche Description and Business Overview
Table 92. Roche Chronic Hepatitis B Oral Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Roche Chronic Hepatitis B Oral Drugs Product
Table 94. Roche Recent Developments/Updates
Table 95. Merck Company Information
Table 96. Merck Description and Business Overview
Table 97. Merck Chronic Hepatitis B Oral Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Merck Chronic Hepatitis B Oral Drugs Product
Table 99. Merck Recent Developments/Updates
Table 100. Johnson & Johnson Company Information
Table 101. Johnson & Johnson Description and Business Overview
Table 102. Johnson & Johnson Chronic Hepatitis B Oral Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Johnson & Johnson Chronic Hepatitis B Oral Drugs Product
Table 104. Johnson & Johnson Recent Developments/Updates
Table 105. Dawnrays Pharmaceutical Company Information
Table 106. Dawnrays Pharmaceutical Description and Business Overview
Table 107. Dawnrays Pharmaceutical Chronic Hepatitis B Oral Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Dawnrays Pharmaceutical Chronic Hepatitis B Oral Drugs Product
Table 109. Dawnrays Pharmaceutical Recent Developments/Updates
Table 110. Hansoh Pharmaceutical Company Information
Table 111. Hansoh Pharmaceutical Description and Business Overview
Table 112. Hansoh Pharmaceutical Chronic Hepatitis B Oral Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Hansoh Pharmaceutical Chronic Hepatitis B Oral Drugs Product
Table 114. Hansoh Pharmaceutical Recent Developments/Updates
Table 115. Chia Tai-Tianqing Pharmaceutical Company Information
Table 116. Chia Tai-Tianqing Pharmaceutical Description and Business Overview
Table 117. Chia Tai-Tianqing Pharmaceutical Chronic Hepatitis B Oral Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Chia Tai-Tianqing Pharmaceutical Chronic Hepatitis B Oral Drugs Product
Table 119. Chia Tai-Tianqing Pharmaceutical Recent Developments/Updates
Table 120. Qilu pharmaceutical Company Information
Table 121. Qilu pharmaceutical Description and Business Overview
Table 122. Qilu pharmaceutical Chronic Hepatitis B Oral Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Qilu pharmaceutical Chronic Hepatitis B Oral Drugs Product
Table 124. Qilu pharmaceutical Recent Developments/Updates
Table 125. Fujian Cosunter Pharma Company Information
Table 126. Fujian Cosunter Pharma Description and Business Overview
Table 127. Fujian Cosunter Pharma Chronic Hepatitis B Oral Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Fujian Cosunter Pharma Chronic Hepatitis B Oral Drugs Product
Table 129. Fujian Cosunter Pharma Recent Developments/Updates
Table 130. Xiamen Amoytop Biotech Company Information
Table 131. Xiamen Amoytop Biotech Description and Business Overview
Table 132. Xiamen Amoytop Biotech Chronic Hepatitis B Oral Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Xiamen Amoytop Biotech Chronic Hepatitis B Oral Drugs Product
Table 134. Xiamen Amoytop Biotech Recent Developments/Updates
Table 135. YaoPharma Company Information
Table 136. YaoPharma Description and Business Overview
Table 137. YaoPharma Chronic Hepatitis B Oral Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. YaoPharma Chronic Hepatitis B Oral Drugs Product
Table 139. YaoPharma Recent Developments/Updates
Table 140. Kelun Pharmaceutical Company Information
Table 141. Kelun Pharmaceutical Description and Business Overview
Table 142. Kelun Pharmaceutical Chronic Hepatitis B Oral Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Kelun Pharmaceutical Chronic Hepatitis B Oral Drugs Product
Table 144. Kelun Pharmaceutical Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Chronic Hepatitis B Oral Drugs Distributors List
Table 148. Chronic Hepatitis B Oral Drugs Customers List
Table 149. Chronic Hepatitis B Oral Drugs Market Trends
Table 150. Chronic Hepatitis B Oral Drugs Market Drivers
Table 151. Chronic Hepatitis B Oral Drugs Market Challenges
Table 152. Chronic Hepatitis B Oral Drugs Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
Table 156. Authors List of This Report
List of Figures
Figure 1. Product Picture of Chronic Hepatitis B Oral Drugs
Figure 2. Global Chronic Hepatitis B Oral Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Chronic Hepatitis B Oral Drugs Market Share by Type: 2024 & 2031
Figure 4. Entecavir Product Picture
Figure 5. Tenofovir Product Picture
Figure 6. Lamivudine Product Picture
Figure 7. Adefovir Product Picture
Figure 8. Telbivudine Product Picture
Figure 9. Others Product Picture
Figure 10. Global Chronic Hepatitis B Oral Drugs Market Value by Application (2020-2031) & (US$ Million)
Figure 11. Global Chronic Hepatitis B Oral Drugs Market Share by Application: 2024 & 2031
Figure 12. Hospital
Figure 13. Clinic
Figure 14. Others
Figure 15. Global Chronic Hepatitis B Oral Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Chronic Hepatitis B Oral Drugs Market Size (2020-2031) & (US$ Million)
Figure 17. Global Chronic Hepatitis B Oral Drugs Sales (2020-2031) & (K Units)
Figure 18. Global Chronic Hepatitis B Oral Drugs Average Price (US$/Unit) & (2020-2031)
Figure 19. Chronic Hepatitis B Oral Drugs Report Years Considered
Figure 20. Chronic Hepatitis B Oral Drugs Sales Share by Manufacturers in 2024
Figure 21. Global Chronic Hepatitis B Oral Drugs Revenue Share by Manufacturers in 2024
Figure 22. Global 5 and 10 Largest Chronic Hepatitis B Oral Drugs Players: Market Share by Revenue in Chronic Hepatitis B Oral Drugs in 2024
Figure 23. Chronic Hepatitis B Oral Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 24. Global Chronic Hepatitis B Oral Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 25. North America Chronic Hepatitis B Oral Drugs Sales Market Share by Country (2020-2031)
Figure 26. North America Chronic Hepatitis B Oral Drugs Revenue Market Share by Country (2020-2031)
Figure 27. United States Chronic Hepatitis B Oral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Canada Chronic Hepatitis B Oral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Europe Chronic Hepatitis B Oral Drugs Sales Market Share by Country (2020-2031)
Figure 30. Europe Chronic Hepatitis B Oral Drugs Revenue Market Share by Country (2020-2031)
Figure 31. Germany Chronic Hepatitis B Oral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. France Chronic Hepatitis B Oral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. U.K. Chronic Hepatitis B Oral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Italy Chronic Hepatitis B Oral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Russia Chronic Hepatitis B Oral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Asia Pacific Chronic Hepatitis B Oral Drugs Sales Market Share by Region (2020-2031)
Figure 37. Asia Pacific Chronic Hepatitis B Oral Drugs Revenue Market Share by Region (2020-2031)
Figure 38. China Chronic Hepatitis B Oral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Japan Chronic Hepatitis B Oral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. South Korea Chronic Hepatitis B Oral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. India Chronic Hepatitis B Oral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Australia Chronic Hepatitis B Oral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. China Taiwan Chronic Hepatitis B Oral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Southeast Asia Chronic Hepatitis B Oral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Latin America Chronic Hepatitis B Oral Drugs Sales Market Share by Country (2020-2031)
Figure 46. Latin America Chronic Hepatitis B Oral Drugs Revenue Market Share by Country (2020-2031)
Figure 47. Mexico Chronic Hepatitis B Oral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Brazil Chronic Hepatitis B Oral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Argentina Chronic Hepatitis B Oral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Middle East and Africa Chronic Hepatitis B Oral Drugs Sales Market Share by Country (2020-2031)
Figure 51. Middle East and Africa Chronic Hepatitis B Oral Drugs Revenue Market Share by Country (2020-2031)
Figure 52. Turkey Chronic Hepatitis B Oral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Saudi Arabia Chronic Hepatitis B Oral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. UAE Chronic Hepatitis B Oral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Global Sales Market Share of Chronic Hepatitis B Oral Drugs by Type (2020-2031)
Figure 56. Global Revenue Market Share of Chronic Hepatitis B Oral Drugs by Type (2020-2031)
Figure 57. Global Chronic Hepatitis B Oral Drugs Price (US$/Unit) by Type (2020-2031)
Figure 58. Global Sales Market Share of Chronic Hepatitis B Oral Drugs by Application (2020-2031)
Figure 59. Global Revenue Market Share of Chronic Hepatitis B Oral Drugs by Application (2020-2031)
Figure 60. Global Chronic Hepatitis B Oral Drugs Price (US$/Unit) by Application (2020-2031)
Figure 61. Chronic Hepatitis B Oral Drugs Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
